Dana–Farber Cancer Institute is a comprehensive cancer treatment and research center in Boston, Massachusetts. It is a principal teaching affiliate of Harvard Medical School, and a founding member of Dana–Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.

Wikipedia
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • A friend or loved one’s cancer diagnosis can spark a flurry of web searches for more information about the disease and the latest treatment options. And while the internet can be a useful research tool, the web can also be home to bogus claims about cancer treatments, scams, and unproven […] The post Cancer Treatment Scams: How to Spot Them appeared first on Dana-Farber Cancer Institute.

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • By Tom Coughlin When a parent hears the gut-wrenching words, “Your child has cancer,” their only thoughts are for the child and how they can get well. Financial concerns are usually not on anyone’s radar. But financial toxicity, as it has been termed, is a reality — especially for approximately […] The post “It Takes a Team to Tackle Cancer” – A Coach’s Perspective appeared first on Dana-Farber Ca...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Whenever Joan Janssen meets fellow ovarian cancer patients, she shares words of wisdom that she’s gained from seven years of living with the disease. “This is a recurring disease; don’t be stunned if it comes back,” she tells them. “You fought it the first time. You can do it even […] The post Living with Ovarian Cancer as a Chronic Disease, and Celebrating Milestones appeared first on Dana-Farber...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Scalp cooling is a treatment aimed at preventing or reducing hair loss during chemotherapy. It involves placing a tight, cooled cap on the head before, during, and after each infusion. The cooling cap is attached to a machine that circulates a liquid coolant through the cap. This cooling process reduces […] The post What Happens When I Wear a Cooling Cap? appeared first on Dana-Farber Cancer Insti...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • There are many types of gene therapy, but all of them involve adding to or modifying the genetic program in a person – his or her DNA blueprint that provides instructions for building and operating the body. Gene therapy technology has been developed over several decades and has been successfully […] The post How Gene Therapy Works in Treating Cancer and Other Conditions appeared first on Dana-Far...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Precision medicine and immunotherapy are changing the landscape of cancer treatment. The aim of precision medicine, sometimes called personalized medicine, is to match treatments to individual patients taking into account their genetic makeup, medical history, test results, and other distinctive characteristics. Unlike precision medicine, immunotherapy is a particular form of treatment, […] The po...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • A radiosensitizer, or a radiosensitizing agent, is a drug that makes cancer cells more vulnerable to radiation therapy. Radiation therapy uses high-energy radiation to shrink tumors by disrupting the DNA of cancer cells, causing them to die. Radiosensitizers can be drugs that kill or inhibit growth of cancer cells, like […] The post What is a Radiosensitizer and How Is It Used in Radiation Therapy...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Epigenetics is the collective name for the processes by which cells designate some genes for use and others for storage. In cancer research, epigenetics is of growing interest as a treatment strategy. Epigenetics plays a key role in an organism’s development. From a single cell, a human embryo must be able to […] The post Epigenetics: How It Works And What It Means for Cancer Research appeared fir...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • What is CNS lymphoma? Central nervous system (CNS) lymphoma is an extremely rare form of non-Hodgkin lymphoma that involves the brain and spinal cord, the primary components of your body’s central nervous system. Non-Hodgkin lymphoma is a type of cancer that originates in lymphocytes, infection-fighting white blood cells that make […] The post What is CNS Lymphoma and How is it Treated? appeared f...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • This originally appeared on Vector, Boston Children’s Hospital’s blog. Cancer and other diseases are now understood to spring from a complex interplay of biological factors rather than any one isolated origin. New research reveals that an equally-nuanced approach to treating high-risk neuroblastoma may be the most effective way to curb […] The post Taking A Sideswipe at High-Risk Neuroblastoma app...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • On what was supposed to be a memorable night for all the right reasons, things suddenly went terribly wrong for Marie Fricker. Arriving at Brigham and Women’s Hospital for the birth of her first grandchild, she began experiencing dueling discomforts that rooted her to a bench in the front lobby: […] The post Brain Cancer Survivor Shares Wisdom and Humor in Book appeared first on Dana-Farber Cancer...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Cancer is largely a disease that affects older people. The median age of a cancer diagnosis is 66 years, and one-fourth of new cancer cases are diagnosed in people aged 65 to 74. Adults are most likely to develop solid tumors such as breast, lung, colorectal, prostate, and bladder cancers. In […] The post Why Are Children More Likely to Get Blood Cancers Than Solid Tumors? appeared first on Dana-F...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
YouTube Video
  • David Steensma, MD leads clinical care for patients with myelodysplastic syndromes (MDS) at Dana-Farber. In this video, he discusses basic, clinical, and population science studies underway at Dana-Farber that aim to develop more effective therapies and improve quality of life for patients with MDS. Learn more about care for MDS patients in Dana-Farber’s Adult Leukemia Center. http://www.dana-farb...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Ovarian cancer often goes undetected before it reaches more invasive stages, but there is one aspect of the disease that frequently remains ignored even after diagnosis: Its impact upon a patient’s sexual health and function. Now, as research and treatment advances are allowing more women to live longer and healthier […] The post New Interventions Address Sexual Health after Ovarian Cancer Treatme...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • It’s not uncommon for cancer patients to take to pen after a diagnosis. Peter Rooney’s taken that to another level. Rooney, a former journalist and author of the book Die Free, captured his cancer journey in the new book Immunopatient: The New Frontier of Curing Cancer. The following excerpt is reprinted […] The post Immunopatient: One Patient’s Story of Cancer and Immunotherapy appeared first on ...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • With more people living longer than ever with chronic or serious illnesses, grandparents with cancer are a rapidly growing group. Here are some tips for how children of almost any age can support a grandmother or grandfather facing cancer. If it has been sometime since you saw your grandparent or […] The post How to Support A Grandparent Who Has Cancer appeared first on Dana-Farber Cancer Institut...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • For decades, some activists have warned of links between fluoride and cancer. But years of research confirm that “there is no reason to believe that fluoride, used in an approved manner, in any way causes disease,” according to Herve Sroussi, DMD, PhD, of the Department of Oral Medicine and Oral […] The post Does Fluoride Cause Cancer? appeared first on Dana-Farber Cancer Institute.

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Scalp hypothermia, more commonly known as scalp cooling, is a relatively new treatment to try to prevent or reduce hair loss during chemotherapy. It involves placing a tight, cooled cap on the head before, during, and after each chemo session. The cooling cap is attached to a machine that circulates […] The post Can Cooling Caps Prevent Chemotherapy Hair Loss? appeared first on Dana-Farber Cancer ...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Cancer therapy is increasingly aimed at the fundamental abnormalities within cancer cells – the genes and proteins that normally keep cell division under control, but are damaged or faulty in tumor cells. To understand which genes are abnormal, where they’re located within the genome, and how they affect cell growth, […] The post How is DNA Sequencing Used in Cancer Therapy? appeared first on Dana...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • The approval of a targeted therapy and an immunotherapy drug for some patients with advanced stomach cancer reflects recent new approaches to this difficult-to-treat cancer that hasn’t had many therapeutic advances in recent years. Stomach cancer, uncommon in the United States but a leading cause of cancer death globally, causes […] The post Stomach Cancer: How Immunotherapy and Targeted Therapy a...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
YouTube Video
  • Eric Jacobsen, MD explains Rosai-Dorfman, a rare form of histiocytosis. In the video, he discusses how Rosai-Dorfman may be treated as well as recent research identifying important mutations present in this disease that may be treated with targeted therapy. These findings offer hope to patients with this condition and may lead to further treatment advances. Learn more about Dana-Farber’s Adult Hi...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Salivary gland cancer, a type of head and neck cancer, is a rare disease in which cancer cells form in the tissues of the salivary glands. It may not cause any symptoms, and it may be found during a regular dental check-up or physical exam. Signs and symptoms may be caused by salivary […] The post Salivary Gland Cancer: What are the Symptoms? appeared first on Dana-Farber Cancer Institute.

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Breast calcifications are signs of cellular turnover – essentially, dead cells – that can be visualized on a mammogram or observed in a breast biopsy. In most cases, mammographic calcifications are associated with changes in benign (normal) breast tissue, though in some cases they can be a sign of early […] The post What Are Breast Calcifications and Do They Turn Into Cancer? appeared first on Dan...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
YouTube Video
  • Irene Ghobrial, MD discusses her team’s genomic analysis of patients with smoldering multiple myeloma (SMM), a precursor to full-blown blood cancer. The study helped identify which patients with SMM are at high risk of progressing to overt myeloma. Learn more about the Center for Prevention of Progression of Blood Cancers. http://www.dana-farber.org/research/departments-centers-and-labs/department...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Small cell lung cancer is the most aggressive type of lung cancer. Unlike its far more common counterpart, non-small cell lung cancer, treatment with immunotherapy drugs hasn’t yet been approved for small cell lung cancer, but some early findings in clinical trials suggest this type of treatment may have potential. […] The post Can Immunotherapy Help Patients with Small Cell Lung Cancer? appeared ...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
YouTube Video
  • Patrick Martin spoke about the care his young wife Meghan received for breast cancer at the ninth annual Beyond Boston Luncheon, held November 09, 2017 by the Executive Council for the Susan F. Smith Center for Women's Cancers at Dana-Farber Cancer Institute. The funds raised at the Luncheon are instrumental in enabling physician-researchers at the Susan F. Smith Center to continue their groundbre...

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
YouTube Video
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Blog Post
  • Survival rates associated with blood cancers such as leukemia, lymphoma, and multiple myeloma have risen for patients of all ages in recent years, but this increase has been relatively smaller in adolescents and young adults – those aged 15-40 – than in children and older adults. There are likely to […] The post Blood Cancers: How Do They Differ in Adults Versus Adolescents? appeared first on Dana...

Out-Market Your Competitors?

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account Log in

By signing up, you agree to the Terms of Service and Privacy Policy.

Out-Market Your Competitors

Get complete competitive insights on over 2.2 million companies to drive your marketing strategy.

Create Free Account

Already a user?  Log in

By signing up, you agree to the Terms of Service and Privacy Policy.